pindolol has been researched along with Angor Pectoris in 111 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficiency of bopindolol (B) in the treatment of moderate stable angina pectoris was compared with that of diltiazem (D) by clinical evaluation and exercise tolerance." | 9.07 | Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem. ( Makov, UE; Meyer, EC; Palant, A, 1991) |
| "10 patients (6 females and 4 males with an average age of 75 years) with stable angina pectoris were treated transdermally with mepindolol in a balanced, randomized, controlled, crossover study to compare the anti-ischemic effects of 12-hour overnight, and 24-hour applications." | 9.07 | Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application. ( Bonelli, J; Gazo, F; Kirsch, P; Liedtke, RK, 1991) |
| "The effects of bopindolol, a new beta-adrenoceptor blocker, on the exercise tolerance of 12 in-patients, mean age 57 (5 years), with stable angina pectoris and documented coronary artery disease were evaluated." | 9.07 | Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action. ( Carboni, GP; D'Ermo, M; Prati, PL; Scardovi, AB, 1991) |
| "The effects of pindolol (mean dose 17 +/- 8 mg/day), a beta-blocking drug with intrinsic sympathomimetic activity (ISA), and propranolol (130 +/- 40 mg/day) on exercise performance in 11 patients with stable angina pectoris were compared." | 9.06 | Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris. ( Lisbona, R; Magder, S; Ripley, R; Sami, M, 1987) |
| "A new transdermal system (BIO TSD) containing the beta-adrenergic blocker mepindolol was assessed in a placebo controlled clinical trial in 12 patients with coronary heart disease." | 9.06 | [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris]. ( Bonelli, J; Gazo, F; Liedtke, RK, 1989) |
| "32 patients with stable angina and a positive symptom-limited exercise test (SLET) were investigated in a double-blind randomized trial in order to assess the therapeutic efficacy of bopindolol or atenolol on the incidence of angina pectoris and on angina pectoris threshold heart rate (ATHR)." | 9.06 | Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial. ( Hertzeanu, H; Kellermann, JJ; Loidl, AF; Shemesh, J, 1989) |
| "3 years) with chronic stable angina pectoris and a positive exercise test were treated with the beta-adrenoceptor antagonists bopindolol at increasing doses of 0." | 9.06 | Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect. ( Fryda-Kaurimsky, Z; Holmes, D; Krueger, K, 1990) |
| "The efficacy of bopindolol and atenolol in the treatment of patients with chronic stable angina pectoris have been compared in a double blind, randomized study." | 9.06 | Comparison of bopindolol and atenolol in chronic stable angina pectoris. ( Fitscha, P; Meisner, W; Tiso, B, 1990) |
| "A new transdermal beta-blocker containing system (Mepindolol BIO TSD) was compared in a placebo controlled cross over trial with a transdermal nitrate system in 14 patients suffering from coronary heart disease with stable angina pectoris." | 9.06 | [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate]. ( Bonelli, J; Falkner, C; Gazo, F; Liedtke, RK, 1990) |
| "Twelve patients with documented coronary arteriosclerosis and severe stable angina pectoris were treated with the beta blocker pindolol, 5 mg four times a day, utilizing a double-blind crossover protocol." | 9.05 | Randomized double-blind study of pindolol in patients with stable angina pectoris. ( Friesinger, GC; Harston, WE, 1982) |
| "In a randomized, controlled study we found a significant decrease in pressure-rate (double) product and an improvement in exercise tolerance in patients with angina pectoris treated with pindolol." | 9.05 | Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol. ( Friesinger, GC; Harston, WE, 1982) |
| "The effect of pindolol, a new beta-blocking agent, was evaluated in 12 patients with proven coronary disease (CAD) and angina pectoris." | 9.05 | Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris. ( Dwyer, EM; Pepe, AJ; Pinkernell, BH, 1982) |
| "The efficacy of two beta-receptor antagonists, propranolol and pindolol, was compared with that of a calcium antagonist, verapamil, in the treatment of exertional angina pectoris in 22 men (mean age 51 years)." | 9.05 | The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris. ( Johnston, DL; Kostuk, WJ; Manyari, DE, 1984) |
| "5 mg) and isosorbide dinitrate (ISDN, 30 mg slow release) was compared with placebo in sixteen patients with stable, exercise-induced angina pectoris." | 9.05 | Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris. ( Dorow, P; Schiess, W, 1984) |
| "To investigate the role of intrinsic sympathomimetic activity on left ventricular (LV) function during antianginal therapy with beta-adrenoreceptor antagonists, 23 patients with chronic, exercise-induced angina pectoris and normal or near normal LV function underwent radionuclide ventriculography at rest and during exercise, during 3 randomly allocated periods: (a) treatment with oral propranolol, a drug without intrinsic sympathomimetic activity, 40 to 80 mg 4 times a day; (2) treatment with pindolol, a drug with marked intrinsic sympathomimetic activity, 5 to 10 mg 2 times a day; and (3) a control period." | 9.05 | Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography. ( Carruthers, SG; Johnston, DJ; Kostuk, WJ; Manyari, DE; Purves, P, 1983) |
| "Twenty-two patients with chronic, stable, exercise-induced angina pectoris were assessed during periods of therapy with propranolol, standard-formulation pindolol, and a slow-release preparation of pindolol." | 9.05 | Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris. ( Parker, JO, 1983) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 9.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "68 patients with angina pectoris were treated 14 days with placebo and four weeks with 15 mg/die pindolol (Visken) in a double blind multicenter study." | 9.04 | [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study]. ( Fitscha, P; Lang, E; Schiess, W, 1979) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 7.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 7.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| "To determine whether the depression of left ventricular pumping activity associated with beta-blockade alone could be offset by a substantial degree of partial agonist activity, the haemodynamic dose-response effects of intravenous propranolol and pindolol were compared in a randomised between-group saline controlled study in twenty patients with angiographically proven coronary artery disease." | 6.65 | Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. ( Ahuja, RC; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH, 1983) |
| " The data suggest that in the treatment of angina on effort, beta blockers should be prescribed according to their pharmacokinetic properties to achieve adequate suppression of the heart rate during exercise." | 6.65 | Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics. ( Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR, 1984) |
| "The efficiency of bopindolol (B) in the treatment of moderate stable angina pectoris was compared with that of diltiazem (D) by clinical evaluation and exercise tolerance." | 5.07 | Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem. ( Makov, UE; Meyer, EC; Palant, A, 1991) |
| "The effects of bopindolol, a new beta-adrenoceptor blocker, on the exercise tolerance of 12 in-patients, mean age 57 (5 years), with stable angina pectoris and documented coronary artery disease were evaluated." | 5.07 | Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action. ( Carboni, GP; D'Ermo, M; Prati, PL; Scardovi, AB, 1991) |
| "10 patients (6 females and 4 males with an average age of 75 years) with stable angina pectoris were treated transdermally with mepindolol in a balanced, randomized, controlled, crossover study to compare the anti-ischemic effects of 12-hour overnight, and 24-hour applications." | 5.07 | Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application. ( Bonelli, J; Gazo, F; Kirsch, P; Liedtke, RK, 1991) |
| "The efficacy of bopindolol and atenolol in the treatment of patients with chronic stable angina pectoris have been compared in a double blind, randomized study." | 5.06 | Comparison of bopindolol and atenolol in chronic stable angina pectoris. ( Fitscha, P; Meisner, W; Tiso, B, 1990) |
| "3 years) with chronic stable angina pectoris and a positive exercise test were treated with the beta-adrenoceptor antagonists bopindolol at increasing doses of 0." | 5.06 | Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect. ( Fryda-Kaurimsky, Z; Holmes, D; Krueger, K, 1990) |
| "A new transdermal beta-blocker containing system (Mepindolol BIO TSD) was compared in a placebo controlled cross over trial with a transdermal nitrate system in 14 patients suffering from coronary heart disease with stable angina pectoris." | 5.06 | [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate]. ( Bonelli, J; Falkner, C; Gazo, F; Liedtke, RK, 1990) |
| "32 patients with stable angina and a positive symptom-limited exercise test (SLET) were investigated in a double-blind randomized trial in order to assess the therapeutic efficacy of bopindolol or atenolol on the incidence of angina pectoris and on angina pectoris threshold heart rate (ATHR)." | 5.06 | Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial. ( Hertzeanu, H; Kellermann, JJ; Loidl, AF; Shemesh, J, 1989) |
| " Ambulatory electrocardiography was used to compare the effects of propranolol and pindolol on symptoms, heart rate, arrhythmias and ST segments." | 5.06 | The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography. ( Ballantyne, D; Northcote, RJ, 1988) |
| " We measured serum lipoproteins during chronic beta-adrenoceptor blockade in patients with stable angina pectoris treated with propranolol (without ISA) (n = 21) or pindolol (with ISA) (n = 19)." | 5.06 | Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions. ( Ballantyne, D; Northcote, RJ, 1987) |
| "The effects of pindolol (mean dose 17 +/- 8 mg/day), a beta-blocking drug with intrinsic sympathomimetic activity (ISA), and propranolol (130 +/- 40 mg/day) on exercise performance in 11 patients with stable angina pectoris were compared." | 5.06 | Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris. ( Lisbona, R; Magder, S; Ripley, R; Sami, M, 1987) |
| "A new transdermal system (BIO TSD) containing the beta-adrenergic blocker mepindolol was assessed in a placebo controlled clinical trial in 12 patients with coronary heart disease." | 5.06 | [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris]. ( Bonelli, J; Gazo, F; Liedtke, RK, 1989) |
| "To investigate the role of intrinsic sympathomimetic activity on left ventricular (LV) function during antianginal therapy with beta-adrenoreceptor antagonists, 23 patients with chronic, exercise-induced angina pectoris and normal or near normal LV function underwent radionuclide ventriculography at rest and during exercise, during 3 randomly allocated periods: (a) treatment with oral propranolol, a drug without intrinsic sympathomimetic activity, 40 to 80 mg 4 times a day; (2) treatment with pindolol, a drug with marked intrinsic sympathomimetic activity, 5 to 10 mg 2 times a day; and (3) a control period." | 5.05 | Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography. ( Carruthers, SG; Johnston, DJ; Kostuk, WJ; Manyari, DE; Purves, P, 1983) |
| "Twelve patients with documented coronary arteriosclerosis and severe stable angina pectoris were treated with the beta blocker pindolol, 5 mg four times a day, utilizing a double-blind crossover protocol." | 5.05 | Randomized double-blind study of pindolol in patients with stable angina pectoris. ( Friesinger, GC; Harston, WE, 1982) |
| "Twenty-two patients with chronic, stable, exercise-induced angina pectoris were assessed during periods of therapy with propranolol, standard-formulation pindolol, and a slow-release preparation of pindolol." | 5.05 | Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris. ( Parker, JO, 1983) |
| "The effect of pindolol, a new beta-blocking agent, was evaluated in 12 patients with proven coronary disease (CAD) and angina pectoris." | 5.05 | Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris. ( Dwyer, EM; Pepe, AJ; Pinkernell, BH, 1982) |
| "5 mg) and isosorbide dinitrate (ISDN, 30 mg slow release) was compared with placebo in sixteen patients with stable, exercise-induced angina pectoris." | 5.05 | Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris. ( Dorow, P; Schiess, W, 1984) |
| "In a randomized, controlled study we found a significant decrease in pressure-rate (double) product and an improvement in exercise tolerance in patients with angina pectoris treated with pindolol." | 5.05 | Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol. ( Friesinger, GC; Harston, WE, 1982) |
| "The efficacy of two beta-receptor antagonists, propranolol and pindolol, was compared with that of a calcium antagonist, verapamil, in the treatment of exertional angina pectoris in 22 men (mean age 51 years)." | 5.05 | The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris. ( Johnston, DL; Kostuk, WJ; Manyari, DE, 1984) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 5.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "68 patients with angina pectoris were treated 14 days with placebo and four weeks with 15 mg/die pindolol (Visken) in a double blind multicenter study." | 5.04 | [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study]. ( Fitscha, P; Lang, E; Schiess, W, 1979) |
| "The effects of beta adrenoceptor blockade with propranolol or pindolol on serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and its subfractions HDL2 and HDL3, serum triglyceride, and Intralipid clearance were studied in 17 normolipidaemic, non-diabetic patients with hypertension or angina pectoris." | 3.67 | Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. ( Dollery, CT; Kaufman, S; Murphy, MB; Sugrue, D; Thompson, GR; Trayner, I; Yasuhara, H, 1984) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 3.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| " Thirty-six subjects (healthy, severe angina pectoris, or acute myocardial infarction) were studied 15 minutes either after the beta 1-selective beta-blocking drug metoprolol had been administered in total doses of 2 and 10 mg intravenously or after pindolol, a beta blocker with intrinsic sympathomimetic activity (ISA), in total doses of 0." | 3.66 | Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity. ( Heikkilä, J; Nieminen, MS, 1982) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 3.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| " The data suggest that in the treatment of angina on effort, beta blockers should be prescribed according to their pharmacokinetic properties to achieve adequate suppression of the heart rate during exercise." | 2.65 | Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics. ( Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR, 1984) |
| "To determine whether the depression of left ventricular pumping activity associated with beta-blockade alone could be offset by a substantial degree of partial agonist activity, the haemodynamic dose-response effects of intravenous propranolol and pindolol were compared in a randomised between-group saline controlled study in twenty patients with angiographically proven coronary artery disease." | 2.65 | Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. ( Ahuja, RC; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH, 1983) |
| " However, as dosage adjustment and close observation may be necessary to minimise side effects, the use of this combination should be limited to hospital practice." | 1.27 | Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy. ( McGourty, JC; Silas, JH; Solomon, SA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 103 (92.79) | 18.7374 |
| 1990's | 8 (7.21) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch-Weser, J | 1 |
| Frishman, WH | 2 |
| Kostis, JB | 4 |
| DeFelice, EA | 1 |
| Frishman, W | 3 |
| Hosler, M | 1 |
| Krieger, SK | 1 |
| Aglitz, N | 1 |
| Kuo, PT | 1 |
| Harston, WE | 2 |
| Friesinger, GC | 2 |
| Witchitz, S | 1 |
| Kolsky, H | 1 |
| Moisson, P | 1 |
| Philippe, B | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Johnston, DL | 1 |
| Manyari, DE | 2 |
| Kostuk, WJ | 2 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Lacy, CR | 1 |
| Krieger, SD | 1 |
| Cosgrove, NM | 1 |
| Quyyumi, AA | 1 |
| Wright, C | 1 |
| Mockus, L | 1 |
| Fox, KM | 1 |
| Simon, H | 1 |
| Schuppan, U | 1 |
| Schiess, W | 4 |
| Bachmann, H | 1 |
| Dorow, P | 1 |
| Carruthers, SG | 1 |
| Johnston, DJ | 1 |
| Purves, P | 1 |
| Parker, JO | 1 |
| Silke, B | 1 |
| Nelson, GI | 1 |
| Ahuja, RC | 1 |
| Okoli, RC | 1 |
| Taylor, SH | 1 |
| Ol'binskaia, LI | 1 |
| Bragina, GI | 1 |
| Murphy, MB | 1 |
| Sugrue, D | 1 |
| Trayner, I | 1 |
| Kaufman, S | 1 |
| Yasuhara, H | 1 |
| Dollery, CT | 1 |
| Thompson, GR | 1 |
| Brandes, JW | 1 |
| Körst, HA | 1 |
| Littmann, KP | 1 |
| Cocco, G | 2 |
| Strozzi, C | 2 |
| Chu, D | 2 |
| Amrein, R | 2 |
| Castagnoli, E | 2 |
| Dwyer, EM | 1 |
| Pepe, AJ | 1 |
| Pinkernell, BH | 1 |
| Eliasson, K | 1 |
| Lins, LE | 1 |
| Sundqvist, K | 1 |
| Storstein, L | 1 |
| Kugler, G | 3 |
| Welzel, D | 2 |
| Heikkilä, J | 1 |
| Nieminen, MS | 1 |
| Hosler, MH | 1 |
| Thorsen, NL | 1 |
| Gonasun, L | 1 |
| Weinstein, J | 2 |
| Roskamm, N | 1 |
| Samek, L | 2 |
| Sturzenhofecker, P | 1 |
| Roskamm, H | 1 |
| Vajola, SF | 1 |
| Romei, E | 1 |
| Lax, A | 1 |
| Jacovella, G | 1 |
| Zamotaev, IP | 1 |
| Lozinskiĭ, LG | 1 |
| Sandomirskiĭ, BL | 1 |
| Maksimova, LN | 1 |
| Harry, JD | 1 |
| Delamare, J | 1 |
| Jullien, G | 1 |
| Arrigo, F | 1 |
| Coglitore, S | 1 |
| Virga, T | 1 |
| Giannetto, M | 1 |
| Bramanti, B | 1 |
| Melluso, C | 1 |
| Consolo, F | 1 |
| Kostis, J | 1 |
| Strom, J | 1 |
| Hossler, M | 1 |
| Elkayam, U | 1 |
| Goldner, S | 1 |
| Silverman, R | 1 |
| Davis, R | 1 |
| Sonnenblick, E | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Lang, E | 1 |
| Fitscha, P | 2 |
| Sowton, E | 1 |
| Das Gupta, DS | 1 |
| Baker, I | 1 |
| Frisch, P | 1 |
| Tamura, K | 1 |
| Ozawa, T | 1 |
| Murooka, H | 1 |
| Gavrilescu, S | 1 |
| Pantzer, M | 1 |
| Greif, S | 1 |
| Roth, F | 1 |
| Harnoncourt, K | 1 |
| Rivier, JL | 1 |
| Desbaillets, P | 1 |
| Feuardent, R | 1 |
| Jaeger, M | 1 |
| Jeanneret, P | 1 |
| Jornod, JC | 1 |
| Reymond, C | 1 |
| Hůla, J | 1 |
| Zikmund, M | 1 |
| Leary, WP | 2 |
| Asmal, AC | 2 |
| Frithz, G | 1 |
| Nordgren, L | 1 |
| Zetterquist, S | 1 |
| Furberg, C | 1 |
| Ringqvist, I | 1 |
| Söderholm, B | 1 |
| Williams, P | 1 |
| Ilyas, M | 1 |
| Jafary, MH | 1 |
| Peracha, MA | 1 |
| Janjua, M | 1 |
| Khan, N | 1 |
| Chapelle, M | 1 |
| Naouri, R | 1 |
| Wolff, F | 1 |
| Jennings, G | 1 |
| Bobik, A | 1 |
| Korner, PI | 1 |
| Latorre, A | 1 |
| Lenti, M | 1 |
| Calabrese, P | 1 |
| Pidrman, V | 1 |
| Moniz De Bettencourt, J | 1 |
| Pinto, BG | 1 |
| Fiegel, G | 1 |
| Certin, M | 1 |
| Wechsler, B | 1 |
| Bletry, O | 1 |
| Godeau, P | 1 |
| Ikeda, M | 1 |
| Nakashima, Y | 1 |
| Meyer, EC | 1 |
| Makov, UE | 1 |
| Palant, A | 1 |
| Carboni, GP | 1 |
| Scardovi, AB | 1 |
| D'Ermo, M | 1 |
| Prati, PL | 1 |
| Bonelli, J | 3 |
| Gazo, F | 3 |
| Kirsch, P | 1 |
| Liedtke, RK | 3 |
| Meisner, W | 1 |
| Tiso, B | 1 |
| Falkner, C | 1 |
| Holmes, D | 1 |
| Fryda-Kaurimsky, Z | 1 |
| Krueger, K | 1 |
| Hertzeanu, H | 1 |
| Shemesh, J | 1 |
| Loidl, AF | 1 |
| Kellermann, JJ | 1 |
| Antalóczy, Z | 1 |
| Kekes, E | 1 |
| McGourty, JC | 1 |
| Silas, JH | 1 |
| Solomon, SA | 1 |
| Gebhardt, VA | 1 |
| Wisenberg, G | 1 |
| Fitzgerald, JD | 1 |
| Halawa, B | 1 |
| James, MA | 1 |
| Papouchado, M | 1 |
| Jordan, SC | 1 |
| Northcote, RJ | 2 |
| Ballantyne, D | 2 |
| Magder, S | 1 |
| Sami, M | 1 |
| Ripley, R | 1 |
| Lisbona, R | 1 |
| Oulhaci, M | 1 |
| Merad, B | 1 |
| Toumi, N | 1 |
| Ait-Amar, M | 1 |
| Boudjellab, A | 1 |
| Issad, M | 1 |
| Piva, G | 1 |
| Mihail, A | 1 |
| Popescu, P | 1 |
| Ioan, A | 1 |
| Bruckner, I | 1 |
| Paraschiv, A | 1 |
| Petrescu, X | 1 |
| Popa, N | 1 |
| Gross, F | 1 |
| Aquaro, G | 1 |
| Pavia, M | 1 |
| Baduini, G | 1 |
| De Vita, C | 1 |
| Cadel, A | 1 |
| Carú, B | 1 |
| Mazzini, C | 1 |
| Parenti, GF | 1 |
| Ganeshan, KP | 1 |
| Xavier, KB | 1 |
| Ducloux, M | 1 |
| Offerhaus, L | 1 |
| Haarmann, K | 1 |
| Neff, K | 1 |
| Prichard, BN | 1 |
| Arstila, M | 1 |
| Kallio, V | 1 |
| Wendelin, H | 1 |
| Bjerle, P | 1 |
| Jacobsson, KA | 1 |
| von Frankenberg, H | 1 |
| Ballnath, H | 1 |
| Thorpe, P | 1 |
| Nigam, PD | 1 |
| Malhotra, AS | 1 |
| Orco, J | 1 |
| Kalitza, A | 1 |
| Takác, M | 1 |
| Klvanová, H | 1 |
| Polcín, R | 1 |
| Nair, DV | 1 |
| Sainani, GS | 1 |
| Mukherjee, AK | 1 |
| Srivastava, BN | 2 |
| Jain, PC | 1 |
| Vyas, GP | 1 |
| Dunér, H | 2 |
| Pernow, B | 2 |
| Delius, L | 1 |
| Lübke, KO | 1 |
| Bloch, A | 1 |
| Horvat, L | 1 |
| Szám, I | 1 |
| Kerkovits, G | 1 |
| Buday, G | 1 |
| Binak, K | 1 |
| Sirmaci, N | 1 |
| Tavşanoğlu, S | 1 |
| Harmanci, N | 1 |
| Dwiveli, RB | 1 |
| Rao, VS | 1 |
| Mehta, GS | 1 |
| Limbourg, P | 1 |
| Just, H | 1 |
| Faerchtein, I | 1 |
| Roque, AF | 1 |
| Kastansky, I | 1 |
| Vichi, FL | 1 |
| Freitas, OC | 1 |
| Fioroni, MA | 1 |
| De Petra, V | 1 |
| Di Michele, R | 1 |
| Cecchetti, E | 1 |
| Meier, J | 1 |
| Baranowski, E | 1 |
| Wagner, E | 1 |
| Waucampt, JJ | 1 |
| Decalf, A | 1 |
| Delmon, A | 1 |
| Goethals, S | 1 |
| Pauchant, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for pindolol and Angor Pectoris
| Article | Year |
|---|---|
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Bronchial Spasm; Double-Blin | 1981 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Clinical experience with bopindolol: summary of poster presentations.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Hemodynamics; Humans; Hypertension; Lipids; Pindolol; | 1991 |
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Anxiety Disorde | 1985 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship | 1974 |
66 trials available for pindolol and Angor Pectoris
| Article | Year |
|---|---|
Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Bronchial Spasm; Double-Blin | 1981 |
Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Diseas | 1982 |
The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Exercise Test; | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Electrocardiography; Half-Life; Heart Rate; | 1984 |
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; | 1984 |
The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
Topics: Adult; Aging; Angina Pectoris; Carteolol; Clinical Trials as Topic; Electrocardiography; Female; Hum | 1983 |
[Treatment of angina pectoris with a beta receptor blocker-nitrate combination. Report on a field study of 3168 patients].
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Female; Humans; Isosorbide Dinitrate; | 1983 |
Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Met | 1984 |
Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
Topics: Adult; Aged; Angina Pectoris; Cardiac Output; Electrocardiography; Exercise Test; Heart Rate; Heart | 1983 |
Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations | 1983 |
Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart; Hemodynam | 1983 |
Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Fa | 1982 |
The effect of pindolol and isosorbide dinitrate and their combination on exercise tolerance and ECG changes in angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Electroca | 1981 |
[Drug therapy of coronary heart disease with nitrisken retard].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Female; Humans; Isos | 1982 |
Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Echocardiography; Exercise Test; | 1982 |
Randomized double-blind study of pindolol in patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Humans; M | 1982 |
[Comparative evaluation of the clinical action of a series of beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Bronchi; Clinical Trials as Topi | 1976 |
Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Chronic Disease; Clinical T | 1976 |
[Double-blind comparative study of pindolol alone and its association with a nitrate derivative].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Double-Blin | 1978 |
[Ergometric study of the association of a beta-blocker and a nitrate derivative].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Clinical | 1978 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Me | 1979 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Nif | 1979 |
[Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Nitroglyceri | 1979 |
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as T | 1975 |
[The prophylactic effect of a combination of pindolol and isosorbide dinitrate on angina pectoris induced by arterial stimulation (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; | 1977 |
[The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) (author's transl)].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; D | 1977 |
[The long-term treatment of angina pectoris with pindolol and isosorbide dinitrate in fixed combination. A multicenter trial (author's transl)].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Humans | 1978 |
Treatment of coexistent angina pectoris and hypertension with prindolol.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Heart Rate; Humans; | 1975 |
Pindolol and alprenolol in angina pectoris: a comparative clinical study.
Topics: Administration, Oral; Adult; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Exercise T | 1975 |
Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; E | 1975 |
Prenylamine lactate in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1976 |
Double blind trial of propranolol and pindolol in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middl | 1975 |
[Treatment of angina pectoris with beta-blockaders and nitrites in a fixed combination (test preparation LBI-45)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Female; Humans; Isosorbid | 1975 |
Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Diltiazem; Drug Administration Schedule; Exercise Test | 1991 |
Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Dose-Response Relationship | 1991 |
Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Coronary Diseas | 1991 |
Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Exercise Test; Fe | 1990 |
Beta-blocker duration of action and implications for therapy.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Circadian Rhythm; Double-Blind Method | 1990 |
[Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pecto | 1990 |
Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Electrocardiog | 1990 |
Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Evaluation; | 1989 |
[Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Disease; Ele | 1989 |
Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Exercise Test; Female; | 1989 |
The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Male; M | 1988 |
Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.
Topics: Adult; Aged; Angina Pectoris; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Mid | 1987 |
Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
Topics: Angina Pectoris; Angiography; Exercise Test; Homeostasis; Humans; Male; Middle Aged; Physical Exerti | 1987 |
[Long-term treatment of angia pectoris with pindolol].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Evaluation Stud | 1973 |
[Use of beta-adrenolytic agent in the treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Evaluation Stud | 1973 |
LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Electrocardiogr | 1972 |
[Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Dru | 1974 |
Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
Topics: Administration, Oral; Adult; Angina Pectoris; Blood Pressure; Cardiac Volume; Depression, Chemical; | 1973 |
Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Topics: Adult; Aged; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiogra | 1974 |
[Therapy of angina pectoris using LBI 45].
Topics: Angina Pectoris; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Isosorbide Dinitrat | 1974 |
Pindolol (Visken) and angina pectoris: a double blind multicentre trial.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Humans; Middle Aged; Pindolol; Placebos; Rec | 1972 |
Prolonged action of pindolol.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Pindolol; Placebos; Propranolol; Time Factors | 1973 |
[Results in the treatment of angina pectoris using the beta blockader LB 46(Visken)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; | 1973 |
A double blind study of Visken LB-46, in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; | 1972 |
A double blind drug trial of LB-46 (visken) in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; | 1972 |
A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; Heart | 1972 |
Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Brachial Artery; Cardiac Catheterization; Cardiac Output; Coronary | 1973 |
[The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Electrocardiogra | 1974 |
[Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Electroca | 1974 |
[Therapy of anginose disorders using the combination beta blockader Prindolol and isosorbide dinitrate. A comparative double-blind cross-over study].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Female; Humans; Isosorbid | 1974 |
Beta-adrenergic-blocker LB46 and isosorbide dinitrate synergism in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Synergism; Female; Humans; Isosorbide D | 1974 |
Effect of beta-blockers in lung functions.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pindolol; | 1974 |
38 other studies available for pindolol and Angor Pectoris
| Article | Year |
|---|---|
[Beta-blockers in effort angina].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Ex | 1983 |
[Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
Topics: Adult; Aged; Angina Pectoris; Exercise Test; Female; Hemodynamics; Humans; Kinetics; Male; Middle Ag | 1984 |
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoprotei | 1984 |
[Myocardial infarct after sudden discontinuation of a beta blocker. Studies after discontinuation of treatment with the combination drug Viskenit].
Topics: Adult; Aged; Angina Pectoris; Drug Administration Schedule; Drug Combinations; Female; Humans; Isoso | 1980 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Nifedipine; Pindo | 1980 |
Peripheral vasospasm during beta-receptor blockade - a comparison between metoprolol and pindolol.
Topics: Adult; Angina Pectoris; Forearm; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propanolamines; Ra | 1982 |
Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Echocardiography; Exercise Test; Female; Heart Ventri | 1982 |
Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity.
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Heart Rate; Humans; Mi | 1982 |
Antianginal and antiarrhythmic effects of pindolol in post-infarct patients.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Heart Rate; Humans; Myocardial Infarction; Physical Exertion; | 1982 |
The effect of pindolol on myocardial release of inosine, hypoxanthine and lactate during pacing-induced angina.
Topics: Adenosine Triphosphate; Angina Pectoris; Cardiac Pacing, Artificial; Female; Humans; Hypoxanthine; H | 1982 |
[Effect of single dose administration of a new beta-blockader (pindolol) prior to onset of angina pectoris as evaluated by exercise tests on a bicycle ergometer].
Topics: Angina Pectoris; Drug Evaluation; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; | 1980 |
[Therapeutic aspects of a case of Prinzmetal's angina].
Topics: Aged; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Drug Therapy, Combination; Electrocardi | 1980 |
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardi | 1977 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
"Near maximal" exercise test by treadmill for evaluation of cardiac function.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Circulat | 1979 |
[Effect of viskenit on the efficiency of the left ventricle in patients with post-infarction angina pectoris - echocardiographic study].
Topics: Angina Pectoris; Echocardiography; Heart Ventricles; Humans; Isosorbide Dinitrate; Male; Myocardial | 1979 |
The effect of pindolol on myocardial release of inosine, hypoxanthine and lactate during pacing-induced angina.
Topics: Angina Pectoris; Cardiac Pacing, Artificial; Heart Rate; Humans; Hypoxanthines; Inosine; Lactates; M | 1979 |
[Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
Topics: Adult; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; | 1976 |
Pindolol: exercise testing and angina.
Topics: Angina Pectoris; Electrocardiography; Exercise Test; Humans; Physical Exertion; Pindolol | 1977 |
[LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Female; | 1976 |
[Changes in cardiac dynamics in angina pectoris and action of propranolol and pindolol in the normal subject and in angina patients].
Topics: Adult; Aged; Angina Pectoris; Cardiac Output; Cardiac Volume; Heart Rate; Hemodynamics; Humans; Midd | 1975 |
[The cardiotropic effect of the beta receptor blockader Prindolol].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Female; Heart; Heart Rate; Humans; Male; Middle Aged; | 1975 |
[Letter: Hypoglycemia during beta blocking treatment].
Topics: Angina Pectoris; Diabetes Complications; Fasting; Humans; Hypoglycemia; Insulin; Insulin Secretion; | 1976 |
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Drug | 1985 |
The role of beta blockade, with and without intrinsic sympathomimetic activity, in preserving compromised left ventricular function in patients with ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Echocar | 1985 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; | 1987 |
Beta blocker treatment for angina with associated bradycardia.
Topics: Angina Pectoris; Atenolol; Bradycardia; Electrocardiography; Exercise Test; Heart Rate; Humans; Male | 1986 |
[A new beta-blocker, LB 46--Visken].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Heart Defects, Congenital; Huma | 1973 |
[On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Angina Pectoris; Humans; Myocardial Infar | 1973 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
[Pindolol in foreign medical practice].
Topics: Adrenergic beta-Antagonists; Adult; Africa, Northern; Angina Pectoris; Arrhythmias, Cardiac; Arterio | 1973 |
[Contraction and output capacity of the heart with coronary disease during beta adrenolysis using LB 46 (visken)].
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Electrocardiography; Heart | 1972 |
[The use of the beta-adrenergic blocker LB-46 (Pindolol) in the treatment of angina poectoris].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Evaluation Studies as Topic; Female; Humans; Mal | 1972 |
A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Male; Mid | 1972 |
[Clinical evaluation of the beta-blockader Pindolol (LB-46) in patients with chronic coronary insufficiency].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Evaluation Studies as Topic; Female; Humans; Male; Mi | 1973 |
[Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris].
Topics: Aged; Angina Pectoris; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Pindolol | 1973 |
[Experimental studies on the cardio-selectivity of pindolol. Studies on healthy subjects, and patients with bronchitis and asthma].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Asthma; Bronchitis; Heart; Humans; Metaproterenol; Pindolol; | 1973 |
[Visken. Study of its action on atrial rhythm disorders and on chronic insufficiency. Apropos of 50 cases].
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Heart Atria; Humans; Middle Aged; Pin | 1973 |